Showing 1 - 2 results of 2 for search 'Agulnik M', query time: 0.02s
Refine Results
-
1
Afatinib: emerging next-generation tyrosine kinase inhibitor for NSCLC by Nelson V, Ziehr J, Agulnik M, Johnson M
Published 2013-03-01
Article -
2
Spotlight on lenvatinib in the treatment of thyroid cancer: patient selection and perspectives by Costa R, Carneiro BA, Chandra S, Pai SG, Chae YK, Kaplan JB, Garrett HB, Agulnik M, Kopp PA, Giles FJ
Published 2016-02-01
Article